Glaukos Corp. (6GJ)
XSTU
Real-time Data
06:00 AM
Day's Range
142.0052 wk Range
63.00Overview - 6GJ - Glaukos Corp.
Key Statistics
Valuation
P/E (Trailing)
‪-41.15‬
PEG Ratio
‪4.66‬
Price / Book
‪11.63‬
Profitability
Gross Margin
‪81.67%‬
Profit Margin
‪55.72%‬
Operating Margin
‪-37.12%‬
Return on Assets
‪-21.00%‬
Return on Equity
‪-28.60%‬
Ownership
Shares Outstanding
58.85M
Price stats
50-Day Avg
‪147.32‬
200-Day Avg
‪114.57‬
Peers - 6GJ - Glaukos Corp.
Peer Comparison
Compared with companies in Medical Devices listed on XSTU.
- 6GJXSTUGlaukos Corp.+49.26%52-week change-41.16P/E (Trailing)‪55.72%‬Profit Margin
- PENXSTUPBF Energy Inc.+68.22%52-week change7.71P/E (Trailing)‪3.93%‬Profit Margin
- HQE1XSTUCytoSorbents Corporation+94.73%52-week change-2.28P/E (Trailing)‪71.47%‬Profit Margin
- LT3XSTUAxogen, Inc.+61.76%52-week change-111.53P/E (Trailing)‪74.31%‬Profit Margin
- NG2XSTUNeogen Corp.+60.50%52-week change-300.00P/E (Trailing)‪46.93%‬Profit Margin
- 51KBXSTUAVITA Medical, Inc.+55.59%52-week change-6.12P/E (Trailing)‪82.13%‬Profit Margin
- HAZXSTUHaemonetics Corporation+53.04%52-week change44.61P/E (Trailing)‪59.03%‬Profit Margin
Profile Summary - 6GJ - Glaukos Corp.
About
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for glaucoma, corneal disorders, and retinal diseases. Its product portfolio includes Micro-Invasive Glaucoma Surgery (MIGS) devices, sustained-release drug delivery systems, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
